CorMedix (CRMD) Net Income Growth (5y) (2015 - 2025)

CorMedix (CRMD) Net Income Growth (5y) (2015 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 CorMedix 4.95 Mn -150.26 Mn 107.31 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.33%
Sep 30, 2025 79.14%
Jun 30, 2025 48.58%
Mar 31, 2025 41.07%
Dec 31, 2024 -8.94%
Sep 30, 2024 11.98%
Jun 30, 2024 -82.64%
Mar 31, 2024 -15.36%
Dec 31, 2023 -54.72%
Sep 30, 2023 0.98%
Jun 30, 2023 -5.67%
Mar 31, 2023 -0.76%
Dec 31, 2022 4.35%
Sep 30, 2022 2.99%
Jun 30, 2022 -1.69%
Mar 31, 2022 0.24%
Dec 31, 2021 -225.89%
Sep 30, 2021 1.25%
Jun 30, 2021 1.05%
Mar 31, 2021 -33.18%